Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
Learn In is an upskilling-as-a-service platform that connects employers and learners.
Marlette Funding is a financial tech company tasked to empower customers.
ClearScore is a fintech company that provides free credit scores, credit reports, and financial product recommendations to consumers.
Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Bambusa Therapeutics operates as biotechnology company.
Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
KNIME provides a platform for end-to-end data science and analytics.
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Belliwelli offers four gut-friendly, plant-based snack bars that caters to people with IBS.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Invus has invested in 108 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Health Care, Biotechnology, Therapeutics, Pharmaceutical, Medical. The firm invests across 36 different industry categories.
Among tracked funding rounds, VeraDermics received $384.4M in a Post-IPO Equity round. Invus's total known invested capital is $5.5B.
Invus's average investment size is $81.9M across its portfolio of 108 companies.
Recent Invus portfolio additions include VeraDermics, Ring Therapeutics, Flare Therapeutics, Learn In, Marlette Funding. These companies were founded in 2020 or later.